Azelaic Acid Esters as Pluripotent Immunomodulatory Molecules: Nutritional Supplements or Drugs
Nutraceuticals · 2021
DOI: 10.3390/nutraceuticals1010006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutraceuticals, 2021. Verfasst von Elzbieta Izbicka und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Azelaic acid and its esters, the azelates, occur naturally in organisms ranging from plants to humans. We have shown that diethyl azelate (DEA) exhibits a broad range of immunomodulatory activities in vitro and in vivo, and mitigates insulin resistance. To further investigate the therapeutic utility of DEA, we evaluated its mutagenicity in Salmonella typhimurium strains, examined metabolism of DEA in rat, dog, monkey and human primary hepatocytes and in human saliva, determined pharmacokinetics of DEA after an oral dose in rats, and queried its physicochemical properties for drug-like characteristics. DEA was not mutagenic in bacterial strains ± rat liver metabolic activation system S-9. It was chemically unstable in hepatocyte culture medium with a half-life of
Zitieren
APA
Izbicka, E., & Streeper, R. T. (2021). Azelaic Acid Esters as Pluripotent Immunomodulatory Molecules: Nutritional Supplements or Drugs. Nutraceuticals. https://doi.org/10.3390/nutraceuticals1010006
Vancouver
Izbicka E, Streeper RT. Azelaic Acid Esters as Pluripotent Immunomodulatory Molecules: Nutritional Supplements or Drugs. Nutraceuticals. 2021. doi:10.3390/nutraceuticals1010006
BibTeX
@article{Izbicka2021,
author = {Izbicka, Elzbieta and Streeper, Robert T.},
title = {Azelaic Acid Esters as Pluripotent Immunomodulatory Molecules: Nutritional Supplements or Drugs},
journal = {Nutraceuticals},
year = {2021},
doi = {10.3390/nutraceuticals1010006}
}
EUVIMED